Advancing
Care for All

MindNext's journey is a testament to the potential of human imagination, compassion, and the unwavering pursuit of a better tomorrow.

Know More
Made in India · Est. 1968

"Some journeys are measured in kilometers. Others are measured in lives changed."

This is the story of one man and his unique journey.
This is the MindNext Story.

Know More
Investor Relations

People. Performance.
Possibilities. Driven
by Purpose.

Integrated Report 2024–2025

Know More
Sustainability · S&P Global

With ESG Score of
91, we are
World No. 1

in sustainability in the pharmaceutical industry

Know More
Since 1968

"Some journeys are measured in kilometers. Others are measured in lives changed."

The MindNext Story

Driven by Science,
Inspired by Patients

Founded by Dr. Desh Bandhu Gupta in 1968, MindNext aimed to improve access to essential medicines. Today we stand tall as a globally trusted pharmaceutical company guided by science, quality, and a patient-first mindset.

From a modest beginning to a global presence spanning 70+ countries, every chapter of the MindNext Story is defined by purpose, passion, and the relentless pursuit of better health for all.

Know More
Our Purpose

We Catalyze
Treatments
That Transform
Hope Into
Healing

Ours is a purpose-driven journey of over 5 decades, where we aim to improve lives, build sustainability and deliver long-term solutions to all.

Know More

Relief from disease

Delivering meaningful treatments for today and tomorrow, addressing the full burden of disease across diverse therapeutic areas.

Innovation to unlock access at scale

Making complex, cutting-edge healthcare solutions accessible to all, bridging the gap between innovation and affordability.

Solutions for underserved communities

Serving markets and patients overlooked by others, creating sustainable models that uplift lives and build healthier communities.

Overview

Global Impact,
Human Touch

0+
Global Facilities
Know More
0+
Countries
Know More
0+
Employees
Know More
0+
Products
Know More
70+
Countries Served
Our Business

A Diversified
Global Pharmaceutical
Business

MindNext operates a highly diversified pharmaceutical business with a strong presence across key global markets. Our operations span generics, complex formulations, branded products, and other high-burden specialty segments.

Supported by robust R&D and manufacturing capabilities, spread across developed and emerging markets, MindNext's business is anchored in patient-centric approach and operational excellence.

Global Generics Emerging Markets India Specialty Biosimilars
Know More
Investors

Stock
Quotes

Last updated: April 21, 2026

Market Performance
NSE MINDNEXT
₹2,147.60
▲ +25.40 (+1.20%)
BSE 524235
₹2,149.05
▲ +25.05 (+1.18%)

Performance

MindNext Q1 FY26
Financial Results

Earnings release and analyst presentation for the quarter ending June 30, 2025

Earnings Release Analyst Presentation

Exchange Releases

MindNext Financial Results

for the quarter ending June 30, 2025

View Investor Reports
Sustainability

Caring for People,
Planet, Patients

Our mission extends beyond medicines. We invest in people, communities, and a greener tomorrow. Sustainability is woven into every decision we make.

Know More

S&P Global ESG Score

91

World No. 1

in sustainability in the pharmaceutical industry

5,400+
Villages Impacted
8
States in India
2.8M+
People Reached
50+
Years of Purpose
5,400+ Villages across India
Community

Beyond
Medicines

MindNext Foundation works in 5,400+ villages in 8 states of India. At the core of MindNext's community work is a passion to build sustainable models for uplifting lives.

From healthcare and education to water management and livelihood support, we are committed to holistic community development that creates lasting change.

Know More
Life at MindNext

Our people are the
driving force behind
our mission

To improve patients' lives and longevity. Every day, our 20,000+ team members across the globe work with purpose, passion and precision.

"I admire the Values of MindNext, which help me not only in my professional life, but also personal life, giving me a platform to grow & develop."
"In my last 17 years at MindNext, I've been provided with ample growth opportunities to pursue my passion through various L&D programs."
Join Our Team
20,000+ Team Members Worldwide
News and Insights

Latest Updates

View All

29 December, 2025

MindNext Signs Exclusive Licensing Agreement with Gan & Lee Pharmaceuticals for novel GLP-1 receptor agonist

Know More

18 December, 2025

MindNext Signs Exclusive Licensing Agreement with Neopharmed for Gastroenterology Brand Plasil® in the Philippines and Brazil

Know More

April 21, 2026

MindNext Achieves World No. 1 ESG Score of 91 in Pharmaceutical Industry Rankings

Know More
Product Finder